Only logged-in users can see full content details
ZAGREB, June 8
(Hina) - The Agency for Medicinal Products and
Medical Devices (HALMED) on Monday began an on-site inspection in the
Institute of Immunology (IMZ), and the findings of the checking will
provide the basis for a decision whether to allow the resumption of
the production of bacterial vaccines and blood products or not.